Angola vs Egypt: Access to anti-retroviral drugs, female
Angola
50.0%
in 2024
Egypt
46.0%
in 2024
Angola rank
122nd
Egypt rank
125th
Access to anti-retroviral drugs, female over time
- Angola
- Egypt
How they compare
Angola currently reports 50.0% against 46.0% in Egypt, a difference of 4.0%.
That makes Angola's figure about 1.1 times Egypt's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Egypt ahead.
Angola ranks 122nd and Egypt ranks 125th of 141 countries.
Angola has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Angola | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.7% | 0.1% | 1.6% | Angola |
| 2010s | 20.6% | 14.0% | 6.6% | Angola |
| 2020s | 43.0% | 36.8% | 6.2% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Angola or Egypt?
- Angola, at 50.0% against 46.0% in Egypt as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Angola and Egypt?
- 4.0%, with Angola ahead.
- How many years of comparable data are there for Angola and Egypt?
- 25 years are reported by both, from 2000 to 2024.
- How do Angola and Egypt rank globally for access to anti-retroviral drugs, female?
- Angola ranks 122nd and Egypt ranks 125th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.